Pleiotropic effects of calcium channel blockers.

Item

http://www.wikidata.org/entity/Q36072052

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Pleiotropic effects of calcium channel blockers.

@ast

Pleiotropic effects of calcium channel blockers.

@en

type

Item

label

Pleiotropic effects of calcium channel blockers.

@ast

Pleiotropic effects of calcium channel blockers.

@en

prefLabel

Pleiotropic effects of calcium channel blockers.

@ast

Pleiotropic effects of calcium channel blockers.

@en

P1476

Pleiotropic effects of calcium channel blockers.

@en

P2093

R Preston Mason

http://www.w3.org/2001/XMLSchema#string

P2860

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constitute

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

Molecular physiology of low-voltage-activated t-type calcium channels

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

Effects of amlodipine on nitric oxide synthase mRNA expression and coronary microcirculation in prolonged nitric oxide blockade-induced hypertensive rats

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

P2888

s11906-012-0269-4

P304

293-303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S11906-012-0269-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225049865

http://www.w3.org/2001/XMLSchema#string

P698

22610475

http://www.w3.org/2001/XMLSchema#string

P921

P932

3388257

http://www.w3.org/2001/XMLSchema#string